Ads
related to: clinical trials phases
Search results
Immunocore advances melanoma trial to phase 3 after FDA talks By Investing.com
Investing.com· 5 hours agoThis decision comes after recent consultations with the U.S. Food and Drug Administration (FDA) and...
SOTIO Biotech doses first subject in Phase I solid tumour treatment trial
Clinical Trials Arena via Yahoo Finance· 12 hours agoSOTIO Biotech has dosed the first subject in its Phase I clinical trial VICTORIA-01 to assess the...
ICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre
Investing.com· 18 hours agoICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre
Insmed stocks soar as Phase III lung disease drug exceeds expectations
Clinical Trials Arena via Yahoo Finance· 12 hours agoThe highly anticipated ASPEN trial (NCT04594369) was a global, randomised, double-blind,...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 hours agoThe event will focus on new interim results from an ongoing Phase 2 clinical trial exploring the use of mavorixafor as a once-daily oral ...
IGC Pharma enrols two subjects in Alzheimer’s therapy trial at Neurostudies
Clinical Trials Arena via Yahoo Finance· 12 hours agoThe product’s formulation includes low doses of Tetrahydrocannabinol (THC), the main psychoactive...
Immunocore gains as Mizuho maintains 'buy' rating By Investing.com
Investing.com· 4 hours agoOn Wednesday, Immunocore Holdings (NASDAQ:IMCR), a biotechnology company, announced a significant...
J&J’s daily add-on pill improves depression and insomnia symptoms, acing phase 3
FierceBiotech· 7 hours agoJohnson & Johnson’s oral add-on drug significantly improved depressive symptoms and sleep outcomes in a phase 3 trial for patients who previously did not ...
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 14 hours agoMerck has reported that its Phase III KEYNOTE-522 clinical trial of KEYTRUDA to treat high-risk,...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 11 hours agoImmunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating ...